SEP-363856

· Otsuka Pharmaceutical Development & Commercialization, Inc.

Drug timelines are a Plus or Pro feature.

19 regulatory and trial events tracked for SEP-363856, covering 2021-09-22 to 2026-04-23. Get the full timeline:

Most recent: Clinical Trial Update: A Trial of the Efficacy and Safety of SEP-363856 in Acutely Psychotic Participants With Schizophrenia [Phase 3]